JAKARTA, Indonesia, Sept. 12 /PRNewswire-FirstCall/ -- Cancer patients in Indonesia will gain access to advanced radiotherapy treatments following the signing of a Memorandum of Understanding (MOU) today between Varian Medical Systems (NYSE: VAR) and Indonesia's first private cancer hospital. Under the MOU, Siloam Hospitals and Varian have agreed to pursue a collaborative relationship to explore opportunities for developing innovative health solutions for delivering world class cancer treatment in Indonesia.
Today's signing ceremony is being carried out by Tim Guertin, CEO of Varian Medical Systems and DR. Mochtar Riady, founder of the Lippo Group, watched by John Heffern, Deputy Chief of Mission at the US Embassy, Dr. Gershu Paul, CEO of Siloam Hospitals and Professor Susan Tai, president of the Mochtar Riady Institute for Nanotechnology.
DR. Riady said, "It is wonderful for the Mochtar Riady Comprehensive Cancer Centre to partner with Varian Medical Systems, which is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. We are very enthusiastic about working with Varian to bring such leading technologies and therapies to Indonesia in our fight against cancer."
The "Building of Hope", which incorporates the MRCCC, is a new 29-story, 210-bed specialist hospital in central Jakarta. One of the top ten tallest hospitals in the world, it is expected to be a major center of excellence for cancer in the Southeast Asia region when operational in December 2009.
"This splendid new facility will be a landmark center and will provide
Indonesia cancer patients with much-needed access to the latest
|SOURCE Varian Medical Systems|
Copyright©2008 PR Newswire.
All rights reserved